REBIWIN-LSR Rabeprazole Sodium IP 20mg (Enteric Coated Pellets) + Levosulpiride (As Sustain Release Pellets) Capsule
WHO-GMP CERTIFIED
4.6 (106 reviews)

REBIWIN-LSR

Molecular Composition

Rabeprazole Sodium IP 20mg (Enteric Coated Pellets) + Levosulpiride (As Sustain Release Pellets) Capsule

Packaging

10x10 ALU-ALU

Segment

Pharmaceutical

Retail Price

₹1828.00

Quality & Storage Information

Brand NameREBIWIN-LSR
Dosage FormTablets/Capsules
CompositionRabeprazole Sodium IP 20mg (Enteric Coated Pellets) + Levosulpiride (As Sustain Release Pellets) Capsule
Packaging10x10 ALU-ALU
Manufacturer StandardsWHO-GMP & ISO 9001:2015 Certified

Product Overview

REBIWIN-LSR is a combination medication developed by a prominent PCD Pharma Company in Ambala, containing Rabeprazole Sodium and Levosulpiride. It is primarily used to treat gastroesophageal reflux disease (GERD) and other acid-related disorders, offering relief from symptoms like heartburn and indigestion while also improving gastric motility.

Enquire Now on WhatsApp

Available for PCD Pharma Franchise and Third-Party Manufacturing.